PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for June 22, 2003 Subscribe to this News Feed    
 

The Science Advisory Board Hosts its Third Snapshots Live Event on Cytokines and Growth Factors Kits and Reagents

The Science Advisory Board held its third live teleconference Snapshots Live on Cytokines and Growth Factor Kits and Reagents on June 11, 2003.

ARLINGTON, VA (PRWEB) June 22, 2003 -- The Science Advisory Board held its third live teleconference Snapshots Live on Cytokines and Growth Factor Kits and Reagents on June 11, 2003. The teleconference joined together members of The Science Advisory Board who participated in a cytokine and growth factor study. The 30-minute teleconference featured a brief online presentation of the results from the Science Advisory Board-sponsored study by an in-house team of analysts.

An MP3 of the teleconference, along with a Power Point presentation can be accessed through The Science Advisory Boards webpage at http://scienceboard.net/snapshotslive/.

By listening to this Snapshots Live recording, science writers can learn more about the technical aspects and capabilities of cytokines and growth factors from practicing scientists. Cytokines and growth factors are small, multifunctional proteins that play critical roles in controlling development and in regulating the bodys responses to disease and infection. Among the clinical applications for cytokine and growth factor research are cancer immunotherapy, wound healing, allergy relief, animal health, treatment of autoimmune disorders, anti-viral therapy, obesity, and disease diagnosis.

Although cytokines and growth factors have been studied for many years, these molecules are taking on new importance for two main reasons: (1) sequencing of the human genome has revealed a variety of potential new drug targets that are related to previously characterized cytokines, growth factors and receptors; and (2) the drug development pipelines of many pharmaceutical companies contain growing numbers of cytokine, growth factor and receptor-based protein drugs, antibodies and small molecule inhibitors.

Future Snapshots Live events include discussions on microbial genotyping and tissue microarrays. If you are interested in listening in on one of these events and asking questions of scientists working in these fields, please contact Dr. Tamara Zemlo at 703. 778.3080 x 25 or at t.zemlo@scienceboard.net for more information.


ABOUT THE SCIENCE ADVISORY BOARD

The Science Advisory Board is an online panel of more than 15,200 scientists, physicians and other life science and medical professionals from 62 countries. By convening electronically, Science Advisory Board members participate in online studies to voice their opinions on issues that directly affect the evolution and development of the tools and techniques of their professions. Scientists can contribute their own views on the tools and techniques of their field by participating at http://www.scienceboard.net. The Science Advisory Board was organized in 1997 by BioInformatics, LLC (http://www.gene2drug.com), a research and consulting firm located in Arlington, VA.

CONTACT:
Dr. Tamara Zemlo
Director, Scientific & Medical Communications
The Science Advisory Board
2111 Wilson Blvd, Suite 250
Arlington, VA 22201
703.778.3080 x25 phone
t.zemlo@scienceboard.net
http://www.scienceboard.net

OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
Tamara Zemlo
The Science Advisory Board
703.778.3080 x25
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.